Your Investment & Business Network Has Everything You Need to Stay Informed and Make Informed Decisions.
⎯ 《 Yibn • Com 》

List of All Articles with Tag 'dr'

Blue-Chip Debt Problems Are Just Getting Started: Credit Weekly
Blue-Chip Debt Problems Are Just Getting Started: Credit Weekly
The corporate bond market seems surprisingly blase about the risk of an economic downturn now. US job growth
2023-07-09 04:52
Chinese Foreign Minister’s Unusual 12-Day Absence Draws Scrutiny
Chinese Foreign Minister’s Unusual 12-Day Absence Draws Scrutiny
Chinese Foreign Minister Qin Gang has been absent from public view for 12 days, an usual absence for
2023-07-07 18:59
European Stocks Are Steady Before US Jobs Data; Miners Climb
European Stocks Are Steady Before US Jobs Data; Miners Climb
European shares were little changed on Friday as investors awaited key US jobs data for further clues on
2023-07-07 18:55
Traders Brace for US Payrolls With Global Yields at 15-Year High
Traders Brace for US Payrolls With Global Yields at 15-Year High
Bond investors are bracing for fresh signs of strength in the US labor market on Friday after Treasuries
2023-07-07 18:22
German Production Drops as Factory Weakness Weighs on Growth
German Production Drops as Factory Weakness Weighs on Growth
German industrial production unexpectedly fell in May, casting a shadow over the recovery in Europe’s largest economy from
2023-07-07 14:28
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:57
Wegovy Maker Sues US Pharmacy to Block Knock-Off
Wegovy Maker Sues US Pharmacy to Block Knock-Off
Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the
2023-07-07 08:25
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:21
Alphabet Exuberance Is Cooling on Wall Street After Stock’s Strong Run
Alphabet Exuberance Is Cooling on Wall Street After Stock’s Strong Run
Once one of the highest-rated stocks on Wall Street, Alphabet Inc. is getting a cooler reception from analysts
2023-07-06 21:49
Insight Partners raises $118 million fund to back underrepresented VCs
Insight Partners raises $118 million fund to back underrepresented VCs
By Krystal Hu Global tech investor Insight Partners has raised $118 million in its second 20/20 Vision Capital
2023-07-06 20:27
Traders Lift Bets on BOE Hiking Interest Rate to 6.5% by March
Traders Lift Bets on BOE Hiking Interest Rate to 6.5% by March
Bets on the trajectory of the Bank of England’s key interest rate surged to the highest level in
2023-07-06 16:23
«29303132»